Influence of the intravenous drip infusion of alendronate on healing of proximal femoral fracture

Influence of the intravenous drip infusion of alendronate on healing of proximal femoral fracture - Influence of the intravenous drip infusion of alendronate on healing of proximal femoral fracture

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000013001

Enrollment

100

Registered

2014-01-29

Start date

2014-01-11

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

osteoporosis proximal femoral fracture

Interventions

alendronate with Alfacalcidol Alfacalcidol without alendronate

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. patients with osteoporosis 2. proximal femoral fracture needs fracture fixation

Exclusion criteria

Exclusion criteria: 1. subtrochanteric fracture 2. alendronate allergy 3. hypocalcemia 4. severe complication of cardiac, renal or hepatic function 5. systemic desease affects bone healing 6. inappropriate patient

Design outcomes

Primary

Measure	Time frame
rate of bony union until 48 weeks after surgical intervention	—

Secondary

Measure	Time frame
1. the time required for bony union after surgical intervention 2. quantitative change of bone density 3. quantitative change of bone metabolic markers	—

Countries

Japan

Contacts

Public Contacttatsuya sato

Asahikawa medical Univ. Department of Artificial Joints

s-tatsu@asahikawa-med.ac.jp0166-68-2512

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026